Platelet aggregation test

FK Fares A. Karamat
DH Deborah L. Horjus
YH Yentl C. Haan
LW Lisa van der Woude
MS Marianne C. Schaap
IO Inge Oudman
GM Gert A. van Montfrans
RN Rienk Nieuwland
GS Gajja S. Salomons
JC Joseph F. Clark
LB Lizzy M. Brewster
ask Ask a question
Favorite

We assessed ADP‐induced platelet aggregation by light transmittance aggregometry (PAP‐8E platelet aggregation profiler, Bio/Data Corporation, Horsham, PA, USA) at baseline and after 7 days of intervention. Citrate‐anticoagulated blood (0.32%) was centrifuged (Rotina 420R, Hettich Lab Technology, Tuttlingen, Germany) for 15 min at 180 g to obtain platelet‐rich plasma. Platelet‐poor plasma was prepared by 10 min centrifugation at 1550 g. Experiments were performed at 37°C under stirring conditions. Thrombin receptor‐activated peptide (TRAP; final concentration 15 μmol l−1, Bachem, Bubendorf, Switzerland) was used to induce maximum platelet aggregation (100%). ADP and arachidonic acid were used to initiate the platelet aggregation in the test, final concentrations of ADP (0.1, 0.2, 0.5, 1.0, 2.0 μmol l−1, Sigma‐Aldrich, St. Louis, MO, USA); arachidonic acid (2 mmol l−1, Sigma‐Aldrich, St. Louis, MO, USA). Aggregations were performed with and without the addition of phosphocreatine (CrP 5 mmol l−1 final concentration; Sigma‐Aldrich, St. Louis, MO, USA).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A